NUVB vs TSHA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
TSHA Captures Institutional Edge (2โ1 Pillars ยท 3โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Taysha Gene Therapies, Inc. Common Stock (TSHA) driven by superior Momentum & Technical, Options & Structure while NUVB counters with relative strength in Growth & Margin. Fundamentally, NUVB trades at N/M Forward P/E with -61.2% operating margin (+242.6% YoY revenue) versus TSHA at N/M Forward P/E and -2998.0% operating margin (+171.3% YoY). In options structure, NUVB sits in BREAKDOWN (26th %ile IV; Dealer Gamma Walls on Pro) against TSHA sits in BREAKDOWN (34th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | NUVB Revenue | TSHA Revenue | NUVB Op. Margin | TSHA Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2022 | N/A | $0M | N/A | -6492.7% | TSHA |
| FY2023 | N/A | $20M | N/A | -468.8% | TSHA |
| FY2024 | $10M | $10M | -7527.3% | -1097.6% | TSHA |
| FY2025 | $60M | $10M | -338.7% | -1130.6% | NUVB |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | NUVB | TSHA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.3B | $1.2B | Larger Scale | NUVB |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +242.6% | +171.3% | Higher Growth | NUVB |
| Operating Margin (TTM) Profitability | -61.2% | -2998.0% | Higher Margin | NUVB |
| Net Profit Margin Profitability | -67.4% | 0.0% | Higher Margin | TSHA |
| Return on Equity (ROE) Capital Efficiency | -49.1% | -54.2% | Higher ROE | NUVB |
| 52-Week Range Position Momentum | 2% ($4โ$10) | 7% ($3โ$7) | Stronger Trend | TSHA |
| Beta / 30D Volatility Risk Regime | 1.52ฮฒ ยท 55% Vol | 1.81ฮฒ ยท 52% Vol | Lower Realized Risk | TSHA |
| Unified Institutional Score Composite Signal | 61.0 / 100 (BUY) | 49.8 / 100 (HOLD) | Higher Composite | NUVB |